Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.89 | 8.00 | 6.83 | 8.16 | 10.26 | 10.45 | 16.07 | 12.10 | 16.95 | 20.30 | 21.03 | 21.42 |
| Expenses | 6.16 | 6.25 | 5.35 | 7.27 | 8.89 | 8.79 | 14.85 | 10.85 | 15.59 | 18.79 | 18.79 | 20.23 |
| Operating Profit | 0.73 | 1.75 | 1.48 | 0.89 | 1.37 | 1.66 | 1.22 | 1.25 | 1.36 | 1.51 | 2.24 | 1.19 |
| OPM % | 10.60% | 21.88% | 21.67% | 10.91% | 13.35% | 15.89% | 7.59% | 10.33% | 8.02% | 7.44% | 10.65% | 5.56% |
| Other Income | 0.00 | 0.00 | -0.05 | 0.01 | 0.00 | 0.01 | 0.06 | 0.01 | 0.00 | 0.01 | 0.04 | 0.18 |
| Interest | 0.05 | 0.06 | 0.04 | 0.08 | 0.18 | 0.20 | 0.17 | 0.16 | 0.16 | 0.15 | 0.17 | 0.28 |
| Depreciation | 0.43 | 0.26 | 0.26 | 0.26 | 0.26 | 0.25 | 0.25 | 0.25 | 0.26 | 0.26 | 0.10 | 0.10 |
| Profit before tax | 0.25 | 1.43 | 1.13 | 0.56 | 0.93 | 1.22 | 0.86 | 0.85 | 0.94 | 1.11 | 2.01 | 0.99 |
| Tax % | 28.00% | 32.87% | 71.68% | 26.79% | 10.75% | 16.39% | 27.91% | 25.88% | 26.60% | 26.13% | 37.81% | 26.26% |
| Net Profit | 0.19 | 0.96 | 0.32 | 0.42 | 0.84 | 1.02 | 0.63 | 0.63 | 0.70 | 0.82 | 1.24 | 0.74 |
| EPS in Rs | 0.30 | 1.49 | 0.50 | 0.65 | 1.30 | 1.58 | 0.98 | 0.98 | 1.09 | 1.27 | 1.93 | 1.15 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.30 | 44.92 | 70.38 | 79.70 |
| Expenses | 9.97 | 14.12 | 9.43 | 11.22 | 11.20 | 20.71 | 17.68 | 16.18 | 22.83 | 40.44 | 64.48 | 73.40 |
| Operating Profit | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.61 | 4.47 | 4.48 | 5.90 | 6.30 |
| OPM % | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 18.24% | 16.37% | 9.97% | 8.38% | 7.90% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.33 | 0.49 | 0.01 | -0.04 | 0.08 | 0.06 | 0.23 |
| Interest | 0.01 | 0.07 | 0.24 | 0.20 | 0.23 | 0.10 | 0.24 | 0.27 | 0.21 | 0.62 | 0.66 | 0.76 |
| Depreciation | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.62 | 1.04 | 0.36 | 0.38 | 0.72 |
| Profit before tax | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.73 | 3.18 | 3.58 | 4.92 | 5.05 |
| Tax % | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.71% | 45.28% | 18.99% | 30.89% | |
| Net Profit | 0.43 | 1.40 | 0.80 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 1.74 | 2.90 | 3.40 | 3.50 |
| EPS in Rs | 0.67 | 2.17 | 1.24 | 1.60 | 2.55 | 5.24 | 3.78 | 3.29 | 2.70 | 4.51 | 5.28 | 5.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 62.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 20% | 23% | 53% | 63% | ||
| Compounded Profit Growth | 23% | 0% | 17% | 12% | ||
| Stock Price CAGR | 11% | -5% | 6% | -20% | ||
| Return on Equity | 15% | 13% | 13% | 14% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.10 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
| Reserves | -0.96 | -0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 13.02 | 15.92 | 19.32 |
| Borrowings | 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 1.24 | 7.41 | 7.79 |
| Other Liabilities | 0.77 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.18 | 6.56 | 7.38 |
| Total Liabilities | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 24.88 | 36.33 | 40.93 |
| Fixed Assets | 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5.00 | 6.56 | 5.52 | 3.93 | 4.16 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 15.14 | 19.36 | 32.40 | 36.77 |
| Total Assets | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 24.88 | 36.33 | 40.93 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.38 | 0.38 | -0.69 | 0.11 | 2.64 | -0.36 | 4.46 | -0.70 | 2.51 | 2.69 | 0.07 | -2.49 |
| Cash from Investing Activity | -0.40 | -0.16 | -1.95 | 0.14 | -0.31 | -0.71 | -2.09 | 0.07 | 0.06 | 0.29 | -5.33 | -2.36 |
| Cash from Financing Activity | 0.11 | 0.01 | 2.06 | -0.42 | -1.60 | 0.32 | 0.32 | -1.20 | -0.53 | 1.19 | 5.40 | -0.17 |
| Net Cash Flow | 0.08 | 0.23 | -0.58 | -0.18 | 0.74 | -0.74 | 2.69 | -1.83 | 2.04 | 4.18 | 0.13 | -5.01 |
| Free Cash Flow | -0.02 | 0.24 | -1.26 | -0.29 | 2.31 | -0.44 | 3.20 | -1.90 | 2.59 | 2.69 | -0.02 | -3.10 |
| CFO/OP | 54% | 40% | -38% | 8% | 166% | -15% | 107% | -18% | 70% | 60% | 2% | -42% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.84 | 27.72 | 100.52 | 139.06 | 94.88 | 182.37 | 87.88 | 131.22 | 136.67 | 100.41 | 99.46 | 92.68 |
| Inventory Days | 218.30 | 143.24 | 115.92 | 202.88 | 149.49 | 92.38 | 64.09 | 106.83 | 141.55 | 93.59 | 66.20 | 55.94 |
| Days Payable | 108.28 | 81.70 | 84.18 | 36.13 | 46.29 | 58.58 | 22.10 | 57.67 | 78.93 | 60.94 | 35.55 | 35.90 |
| Cash Conversion Cycle | 122.86 | 89.26 | 132.26 | 305.81 | 198.08 | 216.16 | 129.86 | 180.37 | 199.29 | 133.06 | 130.10 | 112.71 |
| Working Capital Days | 57.48 | 53.10 | 74.88 | 124.92 | 112.83 | 155.78 | 68.66 | 163.09 | 156.77 | 98.27 | 54.36 | 77.53 |
| ROCE % | 3.31% | 8.83% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 17.97% | 17.90% | 16.64% | 17.62% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% |
| Public | 25.62% | 25.64% | 25.63% | 25.64% | 25.63% | 25.64% | 25.64% | 25.63% | 25.63% | 25.64% | 25.64% | 25.64% |
| No. of Shareholders | 3,241 | 3,271 | 3,387 | 3,966 | 3,834 | 3,864 | 3,849 | 3,752 | 3,778 | 3,705 | 3,638 | 3,628 |
Fundamentals
Market Cap₹ 69.5 Cr.
Current Price₹ 108
Stock P/E19.9
Book Value₹ 40.0
ROCE17.6 %
ROE14.1 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)63%
Compounded Profit Growth (TTM)12%
Standalone figures.
Valuation
Market capRs 69 Cr
Enterprise valueRs 75 Cr
P/E (TTM)19.75x
Price to book2.68x
Price to sales0.87x
EV / EBITDA11.44x
EV / EBIT12.86x
EV / sales0.94x
Earnings yield5.06%
P/E, 3-year average33.12x
P/B, 3-year average3.87x
P/E, 5-year average30.30x
P/B, 5-year average3.75x
Profitability
Operating margin (excl. other income)8.38%
Operating margin (incl. other income)8.47%
EBITDA margin8.19%
Pre-tax margin6.34%
Net profit margin4.39%
Net margin, latest quarter3.45%
ROE14.13%
ROCE17.62%
ROA8.80%
ROE, 3-year average12.45%
ROCE, 3-year average17.30%
ROA, 3-year average8.58%
ROE, 5-year average13.40%
ROCE, 5-year average19.25%
ROA, 5-year average9.88%
ROIC (approx.)12.81%
Tax rate30.89%
Other income / net worth0.23%
Growth
Sales growth (latest year)56.68%
Profit growth (latest year)17.24%
Sales CAGR, 3 years52.64%
Sales CAGR, 5 years23.12%
Profit CAGR, 3 years17.05%
Profit CAGR, 5 years0.18%
Sales growth QoQ1.85%
Profit growth QoQ-40.32%
Sales growth YoY (latest quarter)77.02%
Profit growth YoY (latest quarter)17.46%
Per share
EPS (TTM)Rs 5.44
EPS (latest year)Rs 5.28
EPS (latest quarter)Rs 1.15
EPS, 3-year averageRs 4.16
EPS, 5-year averageRs 3.91
Book value per shareRs 40.02
Sales per shareRs 123.82
Cash flow per shareRs -3.87
Free cash flow per shareRs -4.82
Efficiency
Asset turnover1.72x
Fixed asset turnover16.92x
Inventory turnover6.61x
Inventory days55 days
Debtor days93 days
Debtors turnover3.94x
Creditor days36 days
Cash conversion cycle113 days
Working capital days78 days
Leverage
Total debtRs 8 Cr
Cash and bankRs 2 Cr
Net debtRs 6 Cr
Debt to equity0.30x
Net debt / EBITDA0.85x
Interest coverage7.64x
Owners' fund to total sources62.94%
Debt to assets19.03%
Cash flow
Cash from Operating Activity (latest year)Rs -2 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -5 Cr
Free cash flow (latest year)Rs -3 Cr
FCFE (approx.: FCF + change in debt)Rs -3 Cr
Cash from ops / profit, 5 years0.17x
Statement figures
Net sales (TTM)Rs 80 Cr
Net sales (latest year)Rs 70 Cr
Sales (latest quarter)Rs 21 Cr
Operating profit excl. other income (latest year)Rs 6 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 7 Cr
PBDT (TTM)Rs 6 Cr
Profit before tax (TTM)Rs 5 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 3 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 56 Cr
Total expenditure (latest year)Rs 64 Cr
Total income (latest year)Rs 70 Cr
Share capitalRs 6 Cr
ReservesRs 19 Cr
Shareholders' fundsRs 26 Cr
Total assetsRs 41 Cr
Net blockRs 4 Cr
ReceivablesRs 18 Cr
InventoryRs 8 Cr
Other liabilitiesRs 7 Cr
Shares outstanding (crore)0.64
Ownership
Promoter holding74.37% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 19.8 is at the 4th percentile of its own 9.3-year range
(median 33.1, low 16.9, high 99.8).
P/B 2.68 is the lowest in 9.3 years (median 5.03).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 531398 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.2% | -2.8% | +1.5 pts |
| 1 month | +0.9% | -6.8% | +7.7 pts |
| 3 months | -6.2% | -7.6% | +1.5 pts |
| 3 years | +18.7% | +14.2% | +4.5 pts |
| 5 years | -22.1% | +27.9% | -50.0 pts |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was 3% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 14% of total assets in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹21 Cr +77.0% vs Jun 2025.
Net profit ₹1 Cr +17.5%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd (531398) has a market capitalisation of Rs 69.5 Cr. at the 2026-10-01 close.
What is the P/E ratio of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd trades at a P/E of 19.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Source Natural Foods & Herbal Supplements Ltd's latest quarterly results?
In the Jun 2026 quarter, Source Natural Foods & Herbal Supplements Ltd sales was Rs 21 Cr (+77.0% vs Jun 2025) and net profit was Rs 1 Cr.